Skip to main content
. Author manuscript; available in PMC: 2018 Feb 27.
Published in final edited form as: Ann Surg Oncol. 2011 Aug 12;19(Suppl 3):S483–S490. doi: 10.1245/s10434-011-1971-1

FIG. 2.

FIG. 2

a Annexin V/PI staining of MDA-1986 cells untreated (top) versus treated with KU363 (bottom) for 24 h. b Western Blot analysis of MDA-1986 cells at 24-hour treatment with KU363 for PARP, cleaved PARP, cleaved caspase 3, and β-actin. c Western Blot analysis of MDA-1986 cells at 24-hour treatment with KU363 for p-Akt and β-actin with densitometry measurements in blue. d Western Blot analysis of MDA-1986 cells at 24-hour treatment with KU363 or 17-AAG for Raf-1, total Akt, ErbB2/Her2, and β-actin with densitometry measurements in blue